121 related articles for article (PubMed ID: 22484854)
1. Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation.
Cappelli E; Vecchio D; Frosina G
J Cancer Res Clin Oncol; 2012 May; 138(5):897-9. PubMed ID: 22484854
[TBL] [Abstract][Full Text] [Related]
2. BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells.
Burdak-Rothkamm S; Rothkamm K; McClelland K; Al Rashid ST; Prise KM
Cancer Lett; 2015 Jan; 356(2 Pt B):454-61. PubMed ID: 25304378
[TBL] [Abstract][Full Text] [Related]
3. Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein.
Raso A; Vecchio D; Cappelli E; Ropolo M; Poggi A; Nozza P; Biassoni R; Mascelli S; Capra V; Kalfas F; Severi P; Frosina G
Brain Pathol; 2012 Sep; 22(5):677-88. PubMed ID: 22257080
[TBL] [Abstract][Full Text] [Related]
4. Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin.
Metselaar DS; Meel MH; Benedict B; Waranecki P; Koster J; Kaspers GJL; Hulleman E
EBioMedicine; 2019 Dec; 50():81-92. PubMed ID: 31735550
[TBL] [Abstract][Full Text] [Related]
5. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
6. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
[TBL] [Abstract][Full Text] [Related]
7. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
Park HJ; Kim JK; Jeon HM; Oh SY; Kim SH; Nam DH; Kim H
Mol Cells; 2010 Nov; 30(5):403-8. PubMed ID: 20814749
[TBL] [Abstract][Full Text] [Related]
8. Proton beam radiation induces DNA damage and cell apoptosis in glioma stem cells through reactive oxygen species.
Alan Mitteer R; Wang Y; Shah J; Gordon S; Fager M; Butter PP; Jun Kim H; Guardiola-Salmeron C; Carabe-Fernandez A; Fan Y
Sci Rep; 2015 Sep; 5():13961. PubMed ID: 26354413
[TBL] [Abstract][Full Text] [Related]
9. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract][Full Text] [Related]
10. Identification and isolation of slow-cycling glioma stem cells.
Furst L; Atkins RJ; Dinevska M; Stylli SS; Corcoran NM; Hovens CM; Mantamadiotis T
Methods Cell Biol; 2022; 170():21-30. PubMed ID: 35811101
[TBL] [Abstract][Full Text] [Related]
11. Alternative lengthening of telomeres in human glioma stem cells.
Silvestre DC; Pineda JR; Hoffschir F; Studler JM; Mouthon MA; Pflumio F; Junier MP; Chneiweiss H; Boussin FD
Stem Cells; 2011 Mar; 29(3):440-51. PubMed ID: 21425407
[TBL] [Abstract][Full Text] [Related]
12. FANCD2 knockdown with shRNA interference enhances the ionizing radiation sensitivity of nasopharyngeal carcinoma CNE-2 cells.
Bao Y; Feng H; Zhao F; Zhang L; Xu S; Zhang C; Zhao C; Qin G
Neoplasma; 2021 Jan; 68(1):40-52. PubMed ID: 32940045
[TBL] [Abstract][Full Text] [Related]
13. FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.
Patil AA; Sayal P; Depondt ML; Beveridge RD; Roylance A; Kriplani DH; Myers KN; Cox A; Jellinek D; Fernando M; Carroll TA; Collis SJ
Oncotarget; 2014 Aug; 5(15):6414-24. PubMed ID: 25071006
[TBL] [Abstract][Full Text] [Related]
14. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
15. Radioresistant glioma stem cells--therapeutic obstacle or promising target?
Chalmers AJ
DNA Repair (Amst); 2007 Sep; 6(9):1391-4. PubMed ID: 17482890
[TBL] [Abstract][Full Text] [Related]
16. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
Dunn J; Potter M; Rees A; Rünger TM
Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
[TBL] [Abstract][Full Text] [Related]
17. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.
Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C
Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Fanconi anemia/BRCA pathway at low doses of ionization radiation.
Bosch PC; Bogliolo M; Surrallés J
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():9-13. PubMed ID: 26520367
[TBL] [Abstract][Full Text] [Related]
19. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability.
Bogliolo M; Lyakhovich A; Callén E; Castellà M; Cappelli E; Ramírez MJ; Creus A; Marcos R; Kalb R; Neveling K; Schindler D; Surrallés J
EMBO J; 2007 Mar; 26(5):1340-51. PubMed ID: 17304220
[TBL] [Abstract][Full Text] [Related]
20. TFG-maintaining stability of overlooked FANCD2 confers early DNA-damage response.
Ma C; Hokutan K; Shen Y; Nepal M; Kim JH; Zhang J; Fei P
Aging (Albany NY); 2020 Oct; 12(20):20268-20284. PubMed ID: 33099537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
